Stock Events

Stock Events

Hisamitsu Pharmaceutical 

$29
3
-$7.24-19.98% Wednesday 13:30

Statistics

Day High
29
Day Low
29
52W High
32.3
52W Low
27.52
Volume
100
Avg. Volume
-
Mkt Cap
0
P/E Ratio
14.19
Dividend Yield
1.04%
Dividend
0.3

Upcoming

28
AUG
Dividend Ex
Estimated
 
28
AUG
Dividend Ex
Estimated
 
6
NOV
Dividend Payment
Estimated
 
6
NOV
Dividend Payment
Estimated
 
30
AUG 27
Dividend Ex
Estimated
 

Dividends

1.04%Dividend Yield
Nov 25
$0.1
Nov 25
$0.31
May 25
$0.01
May 25
$0.29
Nov 24
$0.01
10Y Growth
-2.9%
5Y Growth
-6.45%
3Y Growth
-10.87%
1Y Growth
-42.86%

Earnings

9JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.21
0.36
0.5
0.65
Expected EPS
0.27104842292
Actual EPS
N/A

Financials

13.94%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.07BRevenue
288.44MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HTSUF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap293.34B
Novartis is a global healthcare company that manufactures drugs across various therapeutic areas, including pain management, directly competing with Hisamitsu's products.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson offers a broad range of health products, including pharmaceuticals that compete in the pain relief and dermatology sectors, similar to Hisamitsu.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline focuses on pharmaceuticals and healthcare products, including skin health solutions and pain relief medications, competing with Hisamitsu.
Pfizer
PFE
Mkt Cap156.77B
Pfizer operates globally in various therapeutic areas, including pain management, which overlaps with Hisamitsu's product offerings.
Sanofi
SNY
Mkt Cap115.14B
Sanofi produces a wide range of pharmaceutical products, including those for pain relief, directly competing with Hisamitsu's core areas.
Merck
MRK
Mkt Cap294.39B
Merck produces pharmaceuticals that address various health conditions, including pain and skin health, competing with Hisamitsu.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie, a research-based biopharmaceutical company, has products in dermatology and pain management, directly competing with Hisamitsu.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.65B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management therapies, competing in Hisamitsu's market.

About

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Show more...
CEO
Mr. Kazuhide Nakatomi
Employees
2759
Country
Japan
ISIN
JP3784600003

Listings

OTC Link
US
HTSUY
STU
DE
HPX.STU
TSE
JP
4530.TSE
OTC Link
US
HTSUF

0 Comments

Share your thoughts

FAQ

What is Hisamitsu Pharmaceutical stock price today?▼
The current price of HTSUF is $29 USD — it has decreased by -19.98% in the past 24 hours. Watch Hisamitsu Pharmaceutical stock price performance more closely on the chart.
What is Hisamitsu Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hisamitsu Pharmaceutical stocks are traded under the ticker HTSUF.
When is the next Hisamitsu Pharmaceutical earnings date?▼
Hisamitsu Pharmaceutical is going to release the next earnings report on July 09, 2026.
What were Hisamitsu Pharmaceutical earnings last quarter?▼
HTSUF earnings for the last quarter are 0.66 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Hisamitsu Pharmaceutical revenue for the last year?▼
Hisamitsu Pharmaceutical revenue for the last year amounts to 2.07B USD.
What is Hisamitsu Pharmaceutical net income for the last year?▼
HTSUF net income for the last year is 288.44M USD.
Does Hisamitsu Pharmaceutical pay dividends?▼
Yes, HTSUF dividends are paid semi-annual. The last dividend per share was 0.31 USD. As of today, Dividend Yield (FWD)% is 1.04%.
How many employees does Hisamitsu Pharmaceutical have?▼
As of April 23, 2026, the company has 2,759 employees.
In which sector is Hisamitsu Pharmaceutical located?▼
Hisamitsu Pharmaceutical operates in the Health & Wellness sector.
When did Hisamitsu Pharmaceutical complete a stock split?▼
Hisamitsu Pharmaceutical has not had any recent stock splits.
Where is Hisamitsu Pharmaceutical headquartered?▼
Hisamitsu Pharmaceutical is headquartered in Tosu, Japan.